Document Classification

Section Type: RESULTS

Text: After the third dose, the GMTs for those in the standard schedule group who received doses at 0, 2, and 6 months were 5808. 0 (95 % CI, 4961. 4-6799. 0) for HPV-16 and 1729. 9 (95 % CI, 1504. 0-1989. 7) for HPV-18 ; 5368. 5 (95 % CI, 4632. 4-6221. 5) and 1502. 3 (95 % CI, 1302. 1-1733. 2), respectively, for those whose received doses at 0, 3, and 9 months ; 5716. 4 (95 % CI, 4876. 7-6700. 6) and 1581. 5 (95 % CI, 1363. 4-1834. 6), respectively, for those who received doses at 0, 6, and 12 months ; and 3692. 5 (95 % CI, 3145. 3-4334. 9) and 1335. 7 (95 % CI, 1191. 6-1497. 3), respectively, for those who received doses at 0, 12, and 24 months.